FUQA:LSE:LSE-Fidelity US Quality Income ETF Acc (GBX)

ETF | Others |

Last Closing

USD 1053.75

Change

+1.75 (+0.17)%

Market Cap

N/A

Volume

7.72K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+1.02 (+0.76%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 581.04B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.02 (+0.13%)

USD 581.04B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.15 (-0.24%)

USD 266.08B
0QZO:LSE 0QZO

-1.40 (-1.29%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.01 (-0.03%)

USD 239.13B
0QZ3:LSE Qualcomm Inc.

+0.99 (+0.61%)

USD 202.26B
0R24:LSE Intel Corp.

+0.26 (+1.31%)

USD 196.14B

ETFs Containing FUQA:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.06% 71% C- 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.06% 71% C- 69% C-
Trailing 12 Months  
Capital Gain 23.90% 79% B- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.90% 78% C+ 76% C+
Trailing 5 Years  
Capital Gain 84.30% 89% A- 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 84.30% 87% B+ 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 14.98% 78% C+ 78% C+
Dividend Return 14.98% 77% C+ 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.20% 72% C 84% B
Risk Adjusted Return 162.94% 100% F 100% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike